Lux Capital

Activity from announced rounds

Activity in this selectionOct 22, 2026 · AI · Sep 23, 2026

Lux Capital invests in companies emerging from the life sciences, physical sciences and computational sciences, including biotechnology, robotics, aerospace, defence and AI infrastructure.

Its investment approach includes small Seeds, Experiments and Optionality investments that let it engage with technology before a conventional venture case is established. The firm also makes thesis-driven investments and backs founders working on technically difficult problems.

Lux’s Riskgaming programme uses researched scenarios to examine how technological developments interact with geopolitics and national security. That perspective is especially relevant for founders whose commercial opportunity depends on scientific progress, industrial adoption or government demand.

Sources
Rounds participated in
2
Confirmed lead rounds
0
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$1.1B
2 disclosed · full round size, not this investor’s share

By stage

Series C+2

By primary sector

AI1
Biotech1

By country

United States2

Rounds

2 in this selection
Modal Labs

Optimizes AI inference to reduce compute costs and response time

$750MSeries D
Participant
Enveda

Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.

$311MSeries E
Participant